Apomorphine for erectile dysfunction: the desire side of the equation

Apomorphine is a dopamine agonist: it acts on dopamine receptors in the brain rather than on blood vessels. In erectile dysfunction it has been studied as a sublingual medication that supports the central, desire-and-signal side of an erection, the part that PDE5 inhibitors such as sildenafil do not touch. That is why it appears in some compounded combination formulas: the PDE5 inhibitors handle blood flow, and apomorphine addresses the signal that starts the process. Despite the name, it is not an opioid and is chemically unrelated to morphine.

How an erection actually starts

An erection begins in the nervous system. Arousal signals from the brain travel down to the pelvic nerves, which release nitric oxide; nitric oxide relaxes the smooth muscle in the penis and lets blood flow in. PDE5 inhibitors work at the end of that chain, keeping the blood-flow signal switched on longer. Apomorphine works at the beginning: dopamine pathways in the hypothalamus are part of how the brain initiates the response. This is why a man whose main difficulty is initiation, rather than maintenance, sometimes hears about a centrally acting option.

What the research shows

Sublingual apomorphine was studied in randomized trials in the early 2000s and was approved in Europe under the brand name Uprima for erectile dysfunction, though it was later withdrawn from most markets for commercial reasons rather than safety findings. In those trials it improved erections compared with placebo, with a smaller effect than PDE5 inhibitors and with nausea as the most common side effect at higher doses. It was never approved by the FDA for ED. In compounded formulas today it is used at low doses in combination with PDE5 inhibitors, a use that is prescribed off-label by a licensed provider when they judge it appropriate.

Limits and side effects to know

• Nausea, yawning, dizziness and lightheadedness are the side effects most often reported in the trials, and they scale with dose.
• It can lower blood pressure, which matters if you already take blood-pressure medication or have fainted before.
• It does not replace the blood-flow effect of a PDE5 inhibitor; in combination formulas it is a complement, not a substitute.
• Compounded formulas containing apomorphine are not FDA-approved as finished products. A provider reviews your history before prescribing, and sets the dose.

Where it fits in Ignite

Ignite by StaveMD includes low-dose apomorphine alongside sildenafil, tadalafil and L-citrulline in a single sublingual dose, so the formula addresses the signal and the blood flow at the same time. It is prescribed online through our medical network only after a licensed provider reviews a three-minute private intake, and it is filled by a licensed compounding pharmacy. One flat price per pack, no membership fee, full refund if the provider decides it is not a fit.